KR20000056836A - The extracting method of sericin and use thereof - Google Patents

The extracting method of sericin and use thereof Download PDF

Info

Publication number
KR20000056836A
KR20000056836A KR1019990006533A KR19990006533A KR20000056836A KR 20000056836 A KR20000056836 A KR 20000056836A KR 1019990006533 A KR1019990006533 A KR 1019990006533A KR 19990006533 A KR19990006533 A KR 19990006533A KR 20000056836 A KR20000056836 A KR 20000056836A
Authority
KR
South Korea
Prior art keywords
sericin
solvent
aqueous solution
cocoon
extracted
Prior art date
Application number
KR1019990006533A
Other languages
Korean (ko)
Other versions
KR100338684B1 (en
Inventor
김기호
최정도
Original Assignee
정찬복
주식회사 바이오랜드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 정찬복, 주식회사 바이오랜드 filed Critical 정찬복
Priority to KR1019990006533A priority Critical patent/KR100338684B1/en
Publication of KR20000056836A publication Critical patent/KR20000056836A/en
Application granted granted Critical
Publication of KR100338684B1 publication Critical patent/KR100338684B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds

Abstract

PURPOSE: An extraction method of sericin is provided. The sericin has no unpleasant smell and can be used as cosmetic base supplement for moisturizing and elasticity of the skin as the sericin aqueous solution has excellent elastase inhibiting activity and hyaluronase inhibiting activity. CONSTITUTION: An extraction method of sericin comprises the following steps of: selecting and drying cocoon; adding 5-40 times, based on the volume of dried cocoon, of water or buffer solution; boiling at the temperature of 90-130°C for 1/2-1 hours under the condition that a cooling condenser is installed not to distill the solvent; precipitating by using the solvent such as methanol, ethanol, acetone, acetonitrile, tetrahydrofuran or mixture thereof to get the precipitate having no smell; filtering and drying the precipitate.

Description

세리신의 추출방법 및 그 용도 {The extracting method of sericin and use thereof}Extraction method of sericin and its use {The extracting method of sericin and use kind}

본 발명은 세리신의 추출방법 및 그 용도에 관한 것으로, 상세하게는 누에고치로부터 실크 세리신을 추출하는 방법 및 엘라스타제 활성 저해제 및 히아루론라제 활성 저해제로서의 실크 세리신의 용도에 관한 것이다.The present invention relates to a method of extracting sericin and its use, and more particularly, to a method of extracting silk sericin from silkworm cocoon and to the use of silk sericin as an elastase inhibitor and a hyaluronase inhibitor.

피부노화 메카니즘은 자외선이나 외부환경적 요인에 의해 활성 산소나 프리라디칼이 생성 되며,생성된 활성산소나, 프리라디칼에 의해 세포막이 공격을 당하게 되어 피부는 염증(inflammation)이 일어나며, 염증화된(inflammated) 조직은 생리학적 진행 메카니즘에 의해 단백질이나 유전자 물질 등을 파괴 하여 주름 등을 형성하는 피부노화가 일어난다. 피부노화 메카니즘에 관여 되는 단계를 모두 억제, 막아 주는 것이 피부노화를 근본적으로 줄여 줄 수 있다. 상기의 작용을 상세히 설명하면 다음과 같다.In the skin aging mechanism, free radicals or free radicals are generated by ultraviolet rays or external environmental factors. Cell membranes are attacked by the generated free radicals or free radicals, and the skin is inflammated. Inflammated tissue causes skin aging to destroy proteins and genetic material and form wrinkles by physiological progression mechanisms. Inhibiting and preventing all steps involved in the skin aging mechanism can fundamentally reduce skin aging. The above operation is described in detail as follows.

피부에서 엘라스틱 섬유는 콜라겐 섬유와 더불어 진피(epiderm)안쪽에서 가교 결합을 형성한다. 나이가 들어감에 따라 지속적인 자외선 노출이나 피부의 염증반응등과 같은 여러 가지 요인에 의해 섬유아세포로부터 엘라스틴 분해 효소인 엘라스타제 분비작용으로 피부의 탄력이 급격히 저하되고, 함몰(sagging)이 생긴다. 조직학적으로는 염증 세포의 침윤이 증가하며, 엘라스틴 섬유의 결핍과 응집, 콜라겐 섬유의 감소를 보여주며, 생화학적으로는 엘라스타제의 활성도가 현격히 증가한다. 엘라스타제는 엘라스틴을 분해 할 수 있는 지금까지 알려진 유일한 효소이며, 이에 대한 저해는 피부 노화를 근본적으로 줄여 줄 수 있다. 피부 노화를 지연시키기 위하여 종래에는 보습제, 항염증제, 엘라스틴 및 콜라겐 가교 결합이 파괴되어 있는 조직에 영양 및 첨가제 등을 화장료에 배합하는 방법이 이용되고 있는데, 이는 근본적으로 노화를 지연시키는데는 한계가 있는 실정이다. 따라서 피부 탄력을 유지 시키는 엘라스틴 및 콜라겐의 분해를 근본적으로 저해시키는 저해제가 요구되고 있는 실정이다. 종래의 노화 방지 효과를 갖는 원료가 근본적으로 저해하지 못하는 단점으로 인하여 새로운 기능성 물질들을 찾고자 시도되고 있다. 특히, 종래의 동물성 추출물인 콜라겐과 엘라스틴과 유사한 구조를 가진 합성 펩타이드 유도체 등이 사용되고 있으나, 안전성 및 안정성, 그 효과를 충분히 나타내지 못하고 있는 단점으로 인하여 새로운 기능성 물질들을 찾는 노력이 시도되고 있다.In the skin, elastic fibers, along with collagen fibers, form crosslinks inside the dermis. As you age, the elasticity of the elastinase, an elastin-degrading enzyme, is secreted from fibroblasts and causes a sudden decrease in skin elasticity and sagging. Histologically, the infiltration of inflammatory cells is increased, the deficiency and aggregation of elastin fibers, and the reduction of collagen fibers are shown. Biochemically, the activity of elastase is significantly increased. Elastase is the only enzyme known so far to break down elastin, and its inhibition can fundamentally reduce skin aging. In order to delay skin aging, a method of combining nutrition and additives with cosmetics in tissues in which moisturizers, anti-inflammatory agents, elastin and collagen cross-links are broken is used, which is fundamentally limited in delaying aging. to be. Therefore, there is a need for inhibitors that fundamentally inhibit the degradation of elastin and collagen to maintain skin elasticity. Due to the disadvantage that the raw material having a conventional anti-aging effect is not fundamentally inhibited has been attempted to find new functional materials. In particular, synthetic peptide derivatives having a structure similar to that of collagen and elastin, which are conventional animal extracts, are used, but efforts to find new functional substances have been attempted due to the disadvantages of insufficient safety, stability, and effects.

히아루론라제 작용에 대해서 상세히 설명하면, 히아루론라제는 생체중에 ??게 분포하며, 피부에도 존재하는 효소이며, 히아루론산을 분해한다. 히아루론산은 β-D-N-acetylglucosamine 과 β-D-glucouronic acid이 서로 결합한 직쇄상의 고분자 다당이며, 글루코 아미노 글루칸(GAG)의 일종이다. 결합 조직내의 히아루론산의 작용으로는 세포가 수분을 보유하며, 조직내의 메트릭스를 형성하여 세포가 수분을 보유하게 된다. 히아루론산은 나이가 먹음에 따라 감소하고, 그 결과 수분 보유능이 저하되어 노화를 일으킨다. 따라서 히아루론산을 분해하는 히아루론라제의 활성을 억제 하는 것은 제재에 사용 되고 있는 히아루론산의 안정성이나 피부에 도포한 후의 제형에서의 히아루론산 및 피부에 존재하는 히아루론산의 안정성에 기여한다.The hyaluronicase action will be described in detail. The hyaluronate is an enzyme distributed in the living body and is also present in the skin and decomposes hyaluronic acid. Hyaluronic acid is a linear polymer polysaccharide in which β-D-N-acetylglucosamine and β-D-glucouronic acid bind to each other, and is a type of glucosamino glucan (GAG). In the action of hyaluronic acid in the connective tissue, the cells retain moisture, and the matrix forms within the tissue, thereby retaining the moisture. Hyaluronic acid decreases with age, and as a result, water retention decreases, causing aging. Therefore, inhibiting the activity of hyaluronic acid that decomposes hyaluronic acid contributes to the stability of hyaluronic acid used in the preparation and to the stability of hyaluronic acid and hyaluronic acid present in the skin in the formulation after application to the skin.

본 발명은 이러한 견지에서, 자연의 여러 가지 천연물질들 중에서 노화예방에 유효한 물질을 검색한 결과, 누에고치로부터 추출한 추출물이 매우 우수한 엘라스타제 저해 작용, 히아루론라제 저해작용 등의 효능을 나타냄을 발견하였으며 안정성, 안전성 문제를 동시에 해결하였다.In view of the above, the present invention has searched for a material effective in preventing aging among various natural substances, and found that the extract extracted from silkworm cocoon exhibits very good elastase inhibitory effect and hyaluronase inhibitory effect. It solved the stability and safety issues at the same time

그러나, 기존의 누에고치로부터 추출된 실크 세리신(한국특허공개공보 제95-5839 호)은 매우 혐오스런 이취를 냄으로 인하여 화장품 첨가제로 사용하는데 큰 문제점이 있었다.However, the silk sericin (Korean Patent Publication No. 95-5839) extracted from the existing cocoon has a big problem to use as a cosmetic additive due to a very hateful odor.

또, 산화방지제나 티로시나제 저해제로서의 세리신의 이용에 관한 기술은 이미 개발(한국 특허 공개공보 제 98-042150 호)되어져 있는 실정이나 엘라스타제 저해제나 히아루론라제 저해제로서의 용도는 공지되어 있지 아니하였다.Moreover, the situation regarding the use of sericin as an antioxidant or a tyrosinase inhibitor has already been developed (Korean Patent Laid-Open Publication No. 98-042150), and its use as an elastase inhibitor or a hyaluronase inhibitor is not known.

따라서, 본 발명의 목적은 이취가 나지 않는 실크 세리신 추출물 및 그 제조방법을 제공하는데 있다.Accordingly, it is an object of the present invention to provide a silk sericin extract that does not smell off and a preparation method thereof.

본 발명의 다른 목적은 신규의 항엘라스타제 및 항히아루론라제를 제공하는데 있다.Another object of the present invention is to provide novel antielastase and antihyaluronase.

상기, 본 발명의 목적은 누에고치를 선별한 다음 완전 건조한 후 건조중량에 대하여 추출 용매로서 물, 완충수용액을 5-40배 부피량을 가한 다음, 냉각 콘덴서가 장치되어 용매가 증발되는 것을 방지한 상태에서 90-130 C, 30분-10시간 가열하여 추출한 후, 메탄올, 에탄올, 아세톤, 아세토니트릴, 테트라하이드로퓨란 또는 이들의 혼합 용매에 침전시켜 탈취한 고형분을 여과, 건조하는 것을 특징으로 하는 세리신 추출방법에 의해 달성된다.The object of the present invention is to screen the silkworm cocoon and then completely dry and add 5 to 40 times the volume of water and a buffer solution as the extraction solvent with respect to dry weight, and then a cooling condenser is installed to prevent the solvent from evaporating. Sericin, characterized in that the solids extracted by heating 90-130 C, extracted for 30 minutes to 10 hours, precipitated in methanol, ethanol, acetone, acetonitrile, tetrahydrofuran or a mixed solvent thereof are filtered and dried. It is achieved by the extraction method.

본 발명의 목적은 또한, 세리신을 항엘라스타제 및 항히아루론라제로서 이용하는 것에 의해 달성된다.The object of the present invention is also achieved by using sericin as an antielastase and an antihyaluronase.

이하 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.

누에는 한국, 중국 및 동구권 등에서 견사를 수급할 목적으로 다량 양식하고 있으며 우리나라에서는 1960년대 부터 대량으로 양식하여 왔으나 근래에는 견사의 대부분을 수입에 의존하고 있는 실정이다. 본 발명에 사용된 누에고치는 순수 국내산 누에고치로서 출각견에 해당되며 이를 멸균하여 물, 또는 완충수용액에서 일정 비율로 추출한후 메탄올, 에탄올, 아세톤, 아세토니트릴, 테트라하이드로퓨란 또는 이들의 혼합 용매에 침전하여 고형분을 얻는다. 화장료 조성물에 혼합할 경우에는 다시 정제수에 일정량 용해시켜 사용한다. 이 추출물을 화장료, 다시 말하면 영양화장수(로숀), 영양크림, 맛사지 크림, 엣센스, 팩, 유화형 화운데이션 등에 첨가하는 것이다.Silkworms are raised in large quantities for the purpose of supplying and receiving silk in Korea, China and Eastern Europe. In Korea, the silk has been produced in large quantities since the 1960s, but recently, most of the silk is dependent on imports. The silkworm cocoon used in the present invention is a purely domestic silkworm cocoon, which corresponds to a dog dog, which is sterilized and extracted in water or a buffered solution at a predetermined ratio and then precipitated in methanol, ethanol, acetone, acetonitrile, tetrahydrofuran or a mixed solvent thereof. To obtain solids. In the case of mixing with the cosmetic composition, it is used by dissolving a certain amount in purified water again. This extract is added to cosmetics, that is, nourishing cosmetics (lotion), nourishing cream, massage creams, essences, packs, emulsified foundations, and the like.

즉, 일차로 누에고치를 선별한 다음 완전 건조한 후 건조중량에 대하여 추출 용매로서 물, 완충수용액을 5-40배 부피량을 가한다. 추출 방법으로는 냉각 콘덴서가 장치되어 용매가 증발되는 것을 방지한 상태에서 90-130 C, 30분-10시간 가열하여 추출한다. 추출물을 메탄올, 에탄올, 아세톤, 아세토니트릴, 테트라하이드로퓨란 또는 이들의 혼합 용매에 침전하여 탈취한 고형분을 여과, 건조한다. 고형분을 정제수에 0.1-10% 농도로 다시 용해시켜 얻은 추출물을 중량%로 0.1-5%, 바람직하게는 0.5-2%의 양으로 화장료에 첨가하는 것이다.That is, the silkworm cocoon is first screened, and then dried completely, and then 5 to 40 times by volume of water and a buffered aqueous solution are used as the extraction solvent with respect to dry weight. Extraction method is performed by heating at 90-130 C for 30 minutes to 10 hours in a state where a cooling condenser is installed to prevent the solvent from evaporating. The extract is precipitated in methanol, ethanol, acetone, acetonitrile, tetrahydrofuran or a mixed solvent thereof, and the solids deodorized are filtered and dried. The extract obtained by dissolving the solid content again in the concentration of 0.1-10% in purified water is added to the cosmetic in an amount of 0.1-5% by weight, preferably 0.5-2%.

아래의 실시예 및 실험 예는 본 발명의 내용을 설명하나, 본 발명의 내용이 여기에 한정되지는 않는다.The following Examples and Experimental Examples illustrate the content of the invention, but the content of the invention is not limited thereto.

실시예 1.Example 1.

누에고치 100g을 완전 건조시킨 다음 정제수 20kg에 넣고 냉각 콘덴서가 달린 추출기에서 5시간 끓여서 추출한 후 400메쉬 여과포로 여과하고 상온으로 냉각한 후 에탄올 20L에 침전한후 여과하여 10g의 고형분을 얻은 후 다시 물에 용해시켜 0.45μm의 필터로 여과하여 1kg의 수용액을 얻었다.100 g of cocoon is completely dried and then placed in 20 kg of purified water and boiled for 5 hours in an extractor equipped with a cooling condenser. The extract is filtered through a 400 mesh filter cloth, cooled to room temperature, precipitated in 20 L of ethanol and filtered to obtain a solid of 10 g. Was dissolved in and filtered through a filter of 0.45 μm to obtain an aqueous solution of 1 kg.

실시예 2.Example 2.

누에고치 100g을 완전 건조시킨 다음 정제수 20kg에 넣고 냉각 콘덴서가 달린 추출기에서 5시간 끓여서 추출한 후 400 메쉬 여과포로 여과하고 상온으로 냉각한 후 메탄올 20L에 침전한후 여과하여 10g의 고형분을 얻은 후 다시 물에 용해시켜 0.45μm의 필터로 여과하여 1kg 의 수용액을 얻었다.100 g of cocoon is completely dried and then placed in 20 kg of purified water, extracted by boiling in an extractor equipped with a cooling condenser for 5 hours, filtered through a 400 mesh filter cloth, cooled to room temperature, precipitated in 20 L of methanol, filtered, and then filtered to obtain 10 g of solid content. Was dissolved in and filtered through a 0.45 µm filter to obtain an aqueous solution of 1 kg.

실시예 3.Example 3.

누에고치 100g을 완전 건조시킨 다음 0.2M 인산염 완충액 20kg에 넣고 냉각 콘덴서가 달린 추출기에서 3시간 끓여서 추출한 후 400 메쉬 여과포로 여과하고 상온으로 냉각한 후 에탄올 20L에 침전한후 여과하여 15g의 고형분을 얻은 후 다시 물에 용해시켜 0.45μm의 필터로 여과하여 1.5kg 의 수용액을 얻었다.100 g of cocoon was completely dried and then placed in 20 kg of 0.2M phosphate buffer, boiled for 3 hours in an extractor equipped with a cooling condenser, filtered through a 400 mesh filter cloth, cooled to room temperature, precipitated in 20 L of ethanol, and filtered to obtain 15 g of solid content. After dissolving again in water, it filtered with a 0.45 micrometer filter and obtained 1.5 kg of aqueous solution.

실시예 4.Example 4.

누에고치 100g을 완전 건조시킨 다음 0.2M 인산염 완충액 20kg에 넣고 냉각 콘덴서가 달린 추출기에서 3시간 끓여서 추출한 후 400 메쉬 여과포로 여과하고 상온으로 냉각한 후 메탄올 20L에 침전한후 여과하여 15g의 고형분을 얻은 후 다시 물에 용해시켜 0.45μm의 필터로 여과하여 1.5kg 의 수용액을 얻었다.100 g of cocoon was completely dried and then placed in 20 kg of 0.2 M phosphate buffer, boiled for 3 hours in an extractor equipped with a cooling condenser, filtered through a 400 mesh filter cloth, cooled to room temperature, precipitated in 20 L of methanol, and filtered to obtain 15 g of solid content. After dissolving again in water, it filtered with a 0.45 micrometer filter and obtained 1.5 kg of aqueous solution.

실시예 5.Example 5.

누에고치 100g을 완전 건조시킨 다음 정제수 20kg에 넣고 냉각 콘덴서가 달린 추출기에서 3시간 끓여서 추출한 후 400 메쉬 여과포로 여과하고 상온으로 냉각한 후 아세톤 20L에 침전한후 여과하여 8g의 고형분을 얻은 후 다시 물에 용해시켜 0.45μm의 필터로 여과하여 8kg 의 수용액을 얻었다.100 g of cocoon is completely dried and then placed in 20 kg of purified water, extracted by boiling in an extractor equipped with a cooling condenser for 3 hours, filtered through a 400 mesh filter cloth, cooled to room temperature, precipitated in 20 L of acetone, and filtered to obtain 8 g of solid content. Was dissolved in and filtered through a 0.45 µm filter to obtain an 8 kg aqueous solution.

실시예 6.Example 6.

누에고치 100g을 완전 건조시킨 다음 정제수 20kg에 넣고 냉각 콘덴서가 달린 추출기에서 3시간 끓여서 추출한 후 400 메쉬 여과포로 여과하고 상온으로 냉각한 후 아세토나이트릴 20L에 침전한후 여과하여 15g의 고형분을 얻은 후 다시 물에 용해시켜 0.45μm의 필터로 여과하여 1.5kg 의 수용액을 얻었다.After completely drying 100g of cocoon, put it in 20kg of purified water, boil it for 3 hours in an extractor equipped with a cooling condenser, filter it with 400 mesh filter cloth, cool it to room temperature, precipitate it in 20L of acetonitrile, and filter it to obtain 15g solids. The solution was dissolved in water and filtered through a 0.45 µm filter to obtain 1.5 kg of aqueous solution.

실시예 7.Example 7.

누에고치 100g을 완전 건조시킨 다음 정제수 20kg에 넣고 냉각 콘덴서가 달린 추출기에서 3시간 끓여서 추출한 후 400 메쉬 여과포로 여과하고 상온으로 냉각한 후 테트라하이드로퓨란 20L에 침전한후 여과하여 15g의 고형분을 얻은 후 다시 물에 용해시켜 0.45μm의 필터로 여과하여 1.5kg 의 수용액을 얻었다.100g of silkworm cocoons were completely dried and then poured into 20kg of purified water, extracted by boiling in an extractor equipped with a cooling condenser for 3 hours, filtered through a 400 mesh filter cloth, cooled to room temperature, precipitated in 20L of tetrahydrofuran, and filtered to obtain 15g solids. The solution was dissolved in water and filtered through a 0.45 µm filter to obtain 1.5 kg of aqueous solution.

처방예 1.Prescription Example 1.

세리신 수용액을 함유한 화장료중 영양 화장수의(로숀)의 처방예는 다음과 같다.A prescription example of a nourishing lotion (lotion) in cosmetics containing an aqueous solution of sericin is as follows.

여기서 세리신 수용액은 실시예 1의 것을 사용 하였다.Here, the aqueous solution of sericin was used in Example 1.

원 료Raw material 중 량 부Weight part 세리신 수용액Sericin aqueous solution 1.01.0 밀납Beeswax 4.04.0 폴리솔베이트 60Polysorbate 60 1.51.5 솔비탄세스퀴올레이트Sorbitan sesquioleate 0.50.5 유동파라핀Liquid paraffin 5.05.0 스쿠알란Squalane 5.05.0 카프릴릭/카프릭트리글리세라이드Caprylic / Capric Triglycerides 5.05.0 글리세린glycerin 3.03.0 부틸렌글리콜Butylene glycol 3.03.0 프로필렌글리콜Propylene glycol 3.03.0 카르복시비닐폴리머Carboxy Vinyl Polymer 0.10.1 트리에탄올아민Triethanolamine 0.20.2 방부제antiseptic 미량a very small amount 색소Pigment 미량a very small amount 향료Spices 미량a very small amount 정제수Purified water 잔량Remaining amount

처방예 2Prescription Example 2

세리신 수용액을 함유한 화장료중 영양크림의 처방예는 다음과 같다.A prescription example of nutrient cream in cosmetics containing sericin aqueous solution is as follows.

여기서 세리신 수용액은 실시예 1의 것을 말한다.Here, the sericin aqueous solution says the thing of Example 1.

원 료Raw material 중 량 부Weight part 세리신 수용액Sericin aqueous solution 1.01.0 밀납Beeswax 10.010.0 폴리솔베이트 60Polysorbate 60 1.51.5 솔비탄세스퀴올레이트Sorbitan sesquioleate 0.50.5 유동파라핀Liquid paraffin 10.010.0 스쿠알란Squalane 5.05.0 카프릴릭/카프릭트리글리세라이드Caprylic / Capric Triglycerides 5.05.0 글리세린glycerin 5.05.0 부틸렌글리콜Butylene glycol 3.03.0 프로필렌글리콜Propylene glycol 3.03.0 트리에탄올아민Triethanolamine 0.20.2 방부제antiseptic 미량a very small amount 색소Pigment 미량a very small amount 향료Spices 미량a very small amount 정제수Purified water 잔량Remaining amount

처방예 3.Prescription Example 3.

세리신 수용액을 함유한 화장료중 맛사지 크림의 처방예는 다음과 같다.A prescription example of a massage cream in cosmetics containing an aqueous solution of sericin is as follows.

여기서 세리신 수용액은 실시예 1의 것을 말한다.Here, the sericin aqueous solution says the thing of Example 1.

원 료Raw material 중 량 부Weight part 세리신 수용액Sericin aqueous solution 1.01.0 밀납Beeswax 10.010.0 폴리솔베이트 60Polysorbate 60 1.51.5 솔비탄세스퀴올레이트Sorbitan sesquioleate 0.80.8 유동파라핀Liquid paraffin 40.040.0 스쿠알란Squalane 5.05.0 카프릴릭/카프릭트리글리세라이드Caprylic / Capric Triglycerides 4.04.0 글리세린glycerin 5.05.0 부틸렌글리콜Butylene glycol 3.03.0 프로필렌글리콜Propylene glycol 3.03.0 트리에탄올아민Triethanolamine 0.20.2 방부제antiseptic 미량a very small amount 색소Pigment 미량a very small amount 향료Spices 미량a very small amount 정제수Purified water 잔량Remaining amount

처방예 4.Prescription Example 4.

세리신 수용액을 함유한 화장료중 팩의 처방예는 다음과 같다.A prescription example of a pack in cosmetics containing an aqueous solution of sericin is as follows.

여기서 세리신 수용액은 실시예 1의 것을 말한다.Here, the sericin aqueous solution says the thing of Example 1.

원 료Raw material 중 량 부Weight part 세리신 수용액Sericin aqueous solution 1.01.0 폴리비닐알콜Polyvinyl alcohol 13.013.0 소듐카르복시메틸셀룰로스Sodium Carboxymethylcellulose 0.20.2 알란토인Allantoin 0.10.1 에탄올ethanol 5.05.0 노닐페닐에테르Nonylphenyl Ether 0.30.3 방부제antiseptic 미량a very small amount 색소Pigment 미량a very small amount 향료Spices 미량a very small amount 정제수Purified water 잔량Remaining amount

처방예 5Prescription Example 5

세리신 수용액을 함유한 화장료중 유화형 화운데이션의 처방예는 다음과 같다.Prescription examples of emulsified foundations in cosmetics containing sericin aqueous solution are as follows.

여기서 세리신 수용액은 실시예 1의 것을 말한다.Here, the sericin aqueous solution says the thing of Example 1.

원 료Raw material 중 량 부Weight part 세리신 수용액Sericin aqueous solution 1.01.0 밀납Beeswax 2.02.0 사이크로메치콘Pyromethicone 2.02.0 유동파라핀Liquid paraffin 5.05.0 스쿠알란Squalane 5.05.0 스테아린산Stearic acid 2.02.0 카프릴릭/카프릭트리글리세라이드Caprylic / Capric Triglycerides 4.04.0 글리세린glycerin 4.04.0 프로필렌글리콜Propylene glycol 3.03.0 부틸렌글리콜Butylene glycol 3.03.0 트리에탄올아민Triethanolamine 1.01.0 알루미늄마그네슘실리케이트Aluminum Magnesium Silicate 0.50.5 안료Pigment 1212 방부제antiseptic 미량a very small amount 색소Pigment 미량a very small amount 향료Spices 미량a very small amount 정제수Purified water 잔량Remaining amount

실험예 1.Experimental Example 1.

상기 세리신 수용액 1-7 에 대하여 엘라스타제 저해 효과를 측정하였다.The elastase inhibitory effect was measured about the said sericin aqueous solution 1-7.

1) 실험 방법1) Experiment Method

엘라스타제는 돼지 췌장으로부터 추출된 것으로 시그마(Sigma)사의 것을 사용하였다. 췌장 엘라스타제에 의한 합성 팹티드 기질(Sigma)의 가수분해에 근거한 시험법으로 광파장 410㎚에서의 단위 시간당의 4-나이트로아닐린의 방출량의 증가를 엘라스타제의 촉매 활성치로 하였다. 먼저 기질 용액을 200㎕씩 시험관에 넣고, 트리스 완충용액과 증류수를 가한다. 각 세리신 수용액 0.3㎖의 시료액을 반응액에 넣은 뒤 37℃ 항온조에서 10분 동안 반응 시킨다.Elastase was extracted from porcine pancreas and used Sigma. An increase in the amount of 4-nitroaniline released per unit time at a wavelength of 410 nm was determined as the catalytic activity of elastase by a test based on the hydrolysis of synthetic peptide substrate (Sigma) by pancreatic elastase. First, 200 μl of substrate solution is added to the test tube, and Tris buffer solution and distilled water are added. 0.3 ml of each sericin aqueous solution was added to the reaction solution and reacted for 10 minutes in a 37 ° C thermostat.

이때 대조군은 각 실크세리신 수용액 대신 용매만을 0.3㎖씩을 넣고 분광분석계로 파장 410㎚에서의 흡광도를 측정한다. 각 추출물의 엘라스타제 저해 효과는 다음의 공식으로 구한다.In this case, only 0.3 ml of solvent was added instead of each aqueous solution of silk sericin, and the absorbance at wavelength 410 nm was measured with a spectrophotometer. The elastase inhibitory effect of each extract is obtained by the following formula.

엘라스타제 저해율(%) = [ 1 - ( 각 실크세리신 수용액의 효소 활성도/대조군의 효소 활성도) ] X 100% Elastase Inhibition = [1-(Enzyme Activity of Each Silk Sericin Solution / Enzyme Activity of Control)] X 100

결과를 하기 표 1에 게재하였다.The results are shown in Table 1 below.

표 1. 세리신 수용액에 대한 엘라스타제 저해효과Table 1.Elastase Inhibitory Effects on Sericin Aqueous Solution

실 시 예Example 반응액중에 함유시킨 세리신 수용액의 최종 농도(㎍/㎖)Final concentration of sericin aqueous solution contained in the reaction solution (㎍ / ㎖) 엘라스타제 저해율(%)Elastase Inhibition Rate (%) 실시예 1Example 1 157.5157.5 1005010050 실시예 2Example 2 157.5157.5 1005710057 실시예 3Example 3 157.5157.5 1004810048 실시예 4Example 4 157.5157.5 1003510035 실시예 5Example 5 157.5157.5 1006610066 실시예 6Example 6 157.5157.5 1007010070 실시예 7Example 7 157.5157.5 1005310053

실험예 2.Experimental Example 2.

상기 세리신 수용액 1-7의 세리신 수용액에 대하여 히아루론라제 저해 효과를 측정 하였다.Hyaluronase inhibitory effect was measured with respect to the sericin aqueous solution of the sericin aqueous solution 1-7.

1) 실험 방법.1) Experimental method.

히아루론라제(시그마, 타입4)을 사용하여 콤파운드 48/80에 의한 불활성형 효소의 활성화 단계의 저해작용을 중심으로 측정했다. 세리신 수용액 시료를 0.1 M 아세트산 완충용액( pH 4.0) 100 ml에 용해해서 시험관에 넣고, 아세트산 완충용액 50 ml에 용해한 효소 0.1 mg을 가해 37도에서 20분간 방치시킨다. 최후로 아세드산 완충용액 250 ml에 녹인 히아루론산나트륨 200 mg을 가해 37도에서 40분간 방치시킨후 0.4 몰 수산화나트륨 100 ml를 가해 냉각후 붕소산 완충용액(pH 9.1) 100 ml을 가해 37도에서 20분간 항온 시킨 후 585 nm에서 흡광도를 측정한다. 대조로는 세리신 시료용액에 아세트산 완충용액을 사용한다. 대조 시험의 흡광도와 세리신 수용액 함유 흡광도의 비에서 100을 곱하여 저해효과를 ( % )로 나타내었다.Hyalurase (Sigma, Type 4) was used to measure the inhibitory activity of the activation step of the inactive enzyme by compound 48/80. A sample of sericin aqueous solution was dissolved in 100 ml of 0.1 M acetic acid buffer (pH 4.0), placed in a test tube, and 0.1 mg of the enzyme dissolved in 50 ml of acetic acid buffer was added and left to stand at 37 degrees for 20 minutes. Finally, 200 mg of sodium hyaluronate dissolved in 250 ml of acetate buffer was added and allowed to stand at 37 ° C for 40 minutes. After incubation for 20 minutes, absorbance is measured at 585 nm. As a control, acetic acid buffer is used as the sericin sample solution. The inhibitory effect was expressed as (%) by multiplying 100 by the ratio of the absorbance of the control test and the absorbance containing sericin aqueous solution.

결과를 하기 표 2에 게재하였다.The results are reported in Table 2 below.

표 2. 세리신 수용액에 대한 히아루론라제 저해효과Table 2. Effect of Hyaluronase Inhibition on Sericin Aqueous Solution

실 시 예Example 반응액중에 함유시킨 세리신 수용액의 최종 농도(㎍/㎖)Final concentration of sericin aqueous solution contained in the reaction solution (㎍ / ㎖) 히아루론라제 저해율(%)Hyaluronicase Inhibition Rate (%) 실시예 1Example 1 20102010 90429042 실시예 2Example 2 20102010 83448344 실시예 3Example 3 20102010 68326832 실시예 4Example 4 20102010 95489548 실시예 5Example 5 20102010 81408140 실시예 6Example 6 20102010 80348034 실시예 7Example 7 20102010 77357735

실험예 3.Experimental Example 3.

1) 실험방법1) Experiment Method

피부탄력성에 대한 세리신 수용액의 영향을 실험하기 위해 20명의 왼쪽눈 가장자리에 하루에 두번 적용하였다. 처리하지 않은 오른쪽 눈 가장자리는 대조군으로 사용하였다. 세리신 수용액 함유 화장료를 처리하기 전과 처리하고난 14일 후 피부 표면의 피부 탄력성을 Corneometer CM80과 Cutometer SEM 474에 의해 측정 하였다. Corneometer CM 820에 의한 피부 보습 측정은 대조군에 비해 증가한 보습력 값을 %로 나타내었으며, 피검자 20명의 평균값을 결과에 나타내었다. Cutometer SEM 474에 의한 피부 탄력도 측정은 주름의 깊이를 측정하는 것으로서, 값이 적을수록 탄력성이 좋은 것이다. 탄력도 값은 대조군에 비해 감소한 값을 %로 나타내었으며, 피검자 20명의 평균값을 결과에 나타 내었다.To test the effect of sericin aqueous solution on skin elasticity, it was applied twice a day to the left eye edge of 20 people. Untreated right eye edge was used as a control. The skin elasticity of the skin surface was measured by Corneometer CM80 and Cutometer SEM 474 before and 14 days after treatment with the cosmetic solution containing sericin solution. Skin moisture measurement by Corneometer CM 820 showed the increased moisturizing value in% compared to the control group and the average value of 20 subjects was shown in the results. Skin elasticity measurement by Cutometer SEM 474 is a measure of the depth of wrinkles, the smaller the value is the better elasticity. The elasticity value was shown as a percentage decrease compared to the control, and the average value of 20 subjects was shown in the results.

2) 실험 결과2) Experiment result

표 3. 세리신 수용액의 피부 표면 보습 및 탄력도 증가 효과Table 3. Effect of Sericin Aqueous Solution on Skin Surface Moisturizing and Elasticity

처 방 예Prescription 피부보습효과(%)Skin moisturizing effect (%) 피부 탄력도 효과(%)Skin elasticity effect (%) 처방예 1Prescription Example 1 3030 3737 처방예 2Prescription Example 2 3333 3838 처방예 3Prescription Example 3 4040 4949 처방예 4Prescription Example 4 2929 3535 처방예 5Prescription Example 5 3434 4040

본 발명에서 얻어진 세리신 수용액을 화장료 조성물에 일정농도 이상 배합하여 사람 피부에 직접 도포한 실험 결과에서도 뚜렷한 피부 탄력 및 노화로 기인한 피부상태가 개선되는 효과를 발휘하게 됨을 발견하게 되었다.The sericin aqueous solution obtained in the present invention was found to have an effect of improving the skin condition due to obvious skin elasticity and aging even in the experimental results of applying directly to human skin by combining a certain concentration or more in a cosmetic composition.

본 발명의 방법에 의해 추출된 세리신 추출물은 종래 방법에 의해 추출된 세리신 추출물과 달리 이취가 나지 않았으며, 세리신 수용액은 엘라스타제 활성저해효과, 히아루론라제 활성저해효과가 우수하였다. 따라서, 피부의 보습 및 탄력성 증가에 유효한 화장료 첨가제로 이용할 수 있다.The sericin extract extracted by the method of the present invention did not smell off unlike the sericin extract extracted by the conventional method, the aqueous solution of sericin was excellent in the elastase inhibitory effect, hyaluronase inhibitory effect. Therefore, it can be used as a cosmetic additive effective for increasing the moisturizing and elasticity of the skin.

Claims (7)

누에고치로부터 추출한 실크 세리신의 항엘라스타제로서의 용도.Use of silk sericin extracted from silkworm cocoons as anti-elastase. 제 1 항에 있어서, 상기 추출은 누에고치를 선별한 다음 완전 건조한 후 건조중량에 대하여 추출 용매로서 물, 완충수용액을 5-40배 부피량을 가한 다음, 냉각 콘덴서가 장치되어 용매가 증발되는 것을 방지한 상태에서 90-130 C, 30분-10시간 가열하여 추출한 후, 메탄올, 에탄올, 아세톤, 아세토니트릴, 테트라하이드로퓨란 또는 이들의 혼합 용매에 침전시켜 탈취한 고형분을 여과, 건조하는 방법으로 수행되는 것을 특징으로 하는 방법.The method of claim 1, wherein the extraction is selected after the cocoon and dried completely, 5-5 times the volume of water and a buffer solution as the extraction solvent with respect to dry weight, and then a cooling condenser is installed to evaporate the solvent. Extracted by heating at 90-130 C for 30 minutes to 10 hours in a prevented state, and then precipitated in methanol, ethanol, acetone, acetonitrile, tetrahydrofuran or a mixed solvent thereof to perform deodorizing solids by filtration and drying. Characterized in that the method. 누에고치로부터 추출한 실크 세리신의 항히아루론라제로서의 용도.Use of silk sericin extracted from cocoon as antihyaluronase. 제 3 항에 있어서, 상기 추출은 누에고치를 선별한 다음 완전 건조한 후 건조중량에 대하여 추출 용매로서 물, 완충수용액을 5-40배 부피량을 가한 다음, 냉각 콘덴서가 장치되어 용매가 증발되는 것을 방지한 상태에서 90-130 C, 30분-10시간 가열하여 추출한 후, 메탄올, 에탄올, 아세톤, 아세토니트릴, 테트라하이드로퓨란 또는 이들의 혼합 용매에 침전시켜 탈취한 고형분을 여과, 건조하는 방법으로 수행되는 것을 특징으로 하는 방법.The method of claim 3, wherein the extraction is selected for the cocoon and dried completely, and then 5-5 times the volume of water and a buffered solution as the extraction solvent with respect to dry weight, and then a cooling condenser is installed to evaporate the solvent. Extracted by heating at 90-130 C for 30 minutes to 10 hours in a prevented state, and then precipitated in methanol, ethanol, acetone, acetonitrile, tetrahydrofuran or a mixed solvent thereof to perform deodorizing solids by filtration and drying. Characterized in that the method. 누에고치를 선별한 다음 완전 건조한 후 건조중량에 대하여 추출 용매로서 물, 완충수용액을 5-40배 부피량을 가한 다음, 냉각 콘덴서가 장치되어 용매가 증발되는 것을 방지한 상태에서 90-130 C, 30분-10시간 가열하여 추출한 후, 메탄올, 에탄올, 아세톤, 아세토니트릴, 테트라하이드로퓨란 또는 이들의 혼합 용매에 침전시켜 탈취한 고형분을 여과, 건조시켜 얻은 실크 세리신의 수용액을 함유한 노화방지 화장료 조성물.After silkworm cocoon is completely dried, add 5-40 times the volume of water and buffered solution as the extraction solvent with respect to dry weight, and then use a cooling condenser to prevent evaporation of the solvent at 90-130 C, Anti-aging cosmetic composition containing an aqueous solution of silk sericin obtained by heating and extracting for 30 minutes to 10 hours, and then filtering and drying the solid deodorized by precipitation in methanol, ethanol, acetone, acetonitrile, tetrahydrofuran or a mixed solvent thereof. . 제 5 항에 있어서, 세리신 수용액의 농도는 0.1-10중량%인 것을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 5, wherein the concentration of the aqueous sericin solution is 0.1-10% by weight. 제 6 항에 있어서, 상기 세리신 수용액을 0.1-5중량%의 양으로 함유함을 특징으로 하는 화장료 조성물.7. The cosmetic composition according to claim 6, wherein the sericin aqueous solution is contained in an amount of 0.1-5% by weight.
KR1019990006533A 1999-02-26 1999-02-26 The extracting method of sericin and use thereof KR100338684B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019990006533A KR100338684B1 (en) 1999-02-26 1999-02-26 The extracting method of sericin and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019990006533A KR100338684B1 (en) 1999-02-26 1999-02-26 The extracting method of sericin and use thereof

Publications (2)

Publication Number Publication Date
KR20000056836A true KR20000056836A (en) 2000-09-15
KR100338684B1 KR100338684B1 (en) 2002-05-30

Family

ID=19575186

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019990006533A KR100338684B1 (en) 1999-02-26 1999-02-26 The extracting method of sericin and use thereof

Country Status (1)

Country Link
KR (1) KR100338684B1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100509717B1 (en) * 2002-07-31 2005-08-23 재단법인서울대학교산학협력재단 Anti-wrinkle cosmetic compositions
KR100676682B1 (en) * 2005-02-03 2007-02-02 주식회사 뉴트렉스테크놀러지 Composition for preventing and treating the xeroderma
CN104324292A (en) * 2014-11-21 2015-02-04 中国药科大学 Traditional Chinese medicine composition for inhibiting activity of elastinase or/and hyaluronidase
CN105343534A (en) * 2015-11-09 2016-02-24 青岛安倍康生物医药技术有限公司 Centella asiatica traditional Chinese medicinal facial mask for treating facial darkness and pigmentation and preparation method of traditional Chinese medicinal facial mask
KR20190058805A (en) * 2017-11-22 2019-05-30 (주)두드림 Cosmetic Composition For Improving Wrinkles Containing Natural Extracts and Culture Media
WO2019139403A1 (en) * 2018-01-11 2019-07-18 주식회사 자연인 Composition containing sericin, torilis japonica extract, and viscum album extract for skin generation, skin soothing, or wound healing

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102508713B1 (en) 2020-08-21 2023-03-10 (주)오렌지다이텍 A method for Recovering High Cocentration Sericin with Non-reagent Degumming
KR102565055B1 (en) 2020-12-24 2023-08-09 (주)오렌지다이텍 A method for Recovering High Cocentration Sericin of low molecular weight with Non-reagent Degumming

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6043044B2 (en) * 1981-08-10 1985-09-26 カネボウ株式会社 skin cosmetics
US6165982A (en) * 1996-11-08 2000-12-26 Seiren Co., Ltd. Use of sericin as antioxidants and tyrosinase inhibitors
JP3950194B2 (en) * 1997-03-03 2007-07-25 セーレン株式会社 Skin inflammation inhibitor

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100509717B1 (en) * 2002-07-31 2005-08-23 재단법인서울대학교산학협력재단 Anti-wrinkle cosmetic compositions
KR100676682B1 (en) * 2005-02-03 2007-02-02 주식회사 뉴트렉스테크놀러지 Composition for preventing and treating the xeroderma
CN104324292A (en) * 2014-11-21 2015-02-04 中国药科大学 Traditional Chinese medicine composition for inhibiting activity of elastinase or/and hyaluronidase
CN105343534A (en) * 2015-11-09 2016-02-24 青岛安倍康生物医药技术有限公司 Centella asiatica traditional Chinese medicinal facial mask for treating facial darkness and pigmentation and preparation method of traditional Chinese medicinal facial mask
KR20190058805A (en) * 2017-11-22 2019-05-30 (주)두드림 Cosmetic Composition For Improving Wrinkles Containing Natural Extracts and Culture Media
WO2019139403A1 (en) * 2018-01-11 2019-07-18 주식회사 자연인 Composition containing sericin, torilis japonica extract, and viscum album extract for skin generation, skin soothing, or wound healing
KR20190085748A (en) * 2018-01-11 2019-07-19 주식회사 자연인 Compositions for skin regeneration, skin soothing or wound healing comprising sericin, extracts of erect hedge parsley extract and extracts of mistletoe
CN110248641A (en) * 2018-01-11 2019-09-17 (株)自然人 Skin regeneration, skin comprising silk gum, common cnidium fruit P.E and Herba Visci extract are releived or wound healing composition

Also Published As

Publication number Publication date
KR100338684B1 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
CA2801048C (en) Antioxidant composition comprising galactomannan and n-acetyl cysteine
CN108473980B (en) Topical composition comprising an extract of small RNA clanis bilineata and cosmetic care method for reducing signs of skin aging
EP0668072B1 (en) Cosmetic composition containing a plant extracellular matrix extract
KR101869971B1 (en) Cosmetic compositon containing natural extracts and natural mineral
KR100338684B1 (en) The extracting method of sericin and use thereof
KR20090070455A (en) Cosmetic composition for skin-aging protection and wrinkle improvement comprising the extract of lithospermum erythrorhizon as active ingredient using a supercritical fluid extract
KR20090104156A (en) Cosmetic composition with the calming effect for skins
KR100954695B1 (en) Cosmetic Composition Comprising the Extract of Abelliophyllum distichum as active Ingredient
JP4768097B2 (en) Active oxygen scavenger, platelet aggregation inhibitor, skin cosmetic and bath preparation
KR101662272B1 (en) Natural cosmetic composition for skin moisturizing comprising Mixed extract of barley and germ and rice bran of black rice and preparation method thereof
KR101042718B1 (en) Cosmetic compositions for preventing skin aging or whitening skin comprising extracts from Ficus erecta Thunb.
KR100295875B1 (en) Cosmetics Containing Green Bean Extract
KR102221627B1 (en) Composition comprising Rhus Semialata extract as active ingredient
JP4413387B2 (en) Collagen production promoter, elastase activity inhibitor, collagenase activity inhibitor and skin cosmetic
KR20120082744A (en) Cosmetic composition
KR20000067187A (en) Cosmetics containing Paeonia Suffruticosa Andrews extracts
JP2004067552A (en) Collagen production promoter, and cosmetic containing the same
KR20180088173A (en) A cosmetic composition comprising extracts of cladosiphon novae - caledoniae kylin
KR20080071386A (en) Anti-wrinkle cosmetic compositions containing extracts of spica prunellae
CN109966372A (en) A kind of Cortex Lycii extract and its new opplication
KR101114499B1 (en) Mixed herb medicine extracts of ficus stipulacea thunb. and lespedeza cuneata g. don for skin-whitening and anti-aging and cosmetic compositions containing the same
KR20220102236A (en) A cosmetic composition for blocking fine dust and anti-aging
KR101008833B1 (en) cosmetic compositions containing extract of Sorbus alnifolia S. et Z. K. Koch used for antiwrinkle
JP4587755B2 (en) Anti-inflammatory agent, whitening agent, anti-aging agent, and skin cosmetic
KR20010055960A (en) Skin care composition containing Cinnamomum cassia extract

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130503

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20140429

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20150430

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20180504

Year of fee payment: 17

EXPY Expiration of term